Skip to main content

Table 1 In-depth interview guide with variant stakeholders

From: Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level

Stakeholders

Open-ended questions

a) The commercial and for-profit sector

b) Policymakers

c) Academic professor in faculty of pharmacy

d) WHO consultant

• Existence of a national medicines regulatory agency (NMRA) responsible for the promulgation and enforcement of regulations.

• Existence of a system for pharmaceutical registration.

• Existence of a pharmacovigilance system.

• Mechanisms exist for licensing, inspection, and quality control.

• Views about different pricing policies.

• Production and trade.

Pharmacists

• Knowledge about the essential drug list (EDL).

• Existence of functioning mechanisms to improve dispensing practices.

• Existence of drug committee and what is its function.

• Opinion about the quality of generic versus brand.

• Percent of prescribed medicines from EDL.

• Percent of medicines prescribed by generic name.

• The percent availability and the average period of stock-outs of unexpired essential tracer medicines.

Physicians

• Prescribing behavior of physicians

• Perception of affordability

• Attitudes of physicians toward generic drugs prescribing

• Relation to medical representatives

• Perception of EDL policies

• Perception and commitment to guidelines’ policies

• Perception and suggestions about pharmaceutical management